Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/29692
Title: Class-Switch Recombination (CSR)/Hyper-IgM (HIGM) Syndromes and Phosphoinositide 3-Kinase (PI3K) Defects
Authors: JHAMNANI, Rekha D.NUNES-SANTOS, Cristiane J.BERGERSON, JennaROSENZWEIG, Sergio D.
Citation: FRONTIERS IN IMMUNOLOGY, v.9, article ID 2172, 12p, 2018
Abstract: Antibody production and function represent an essential part of the immune response, particularly in fighting bacterial and viral infections. Multiple immunological phenotypes can result in dysregulation of the immune system humoral compartment, including class-switch recombination (CSR) defects associated with hyper-IgM(HIGM) syndromes. The CSR/HIGM syndromes are defined by the presence of normal or elevated plasma IgM levels in the context of low levels of switched IgG, IgA, and IgE isotypes. Recently described autosomal dominant gain-of-function (GOF) mutations in PIK3CD and PIK3R1 cause combined immunodeficiencies that can also present as CSR/HIGMdefects. These defects, their pathophysiology and derived clinical manifestations are described in depth. Previously reported forms of CSR/HIGM syndromes are briefly reviewed and compared to the phosphoinositide 3-kinase (PI3K) pathway defects. Diseases involving the PI3K pathway represent a distinctive subset of CSR/HIGM syndromes, presenting with their own characteristic clinical and laboratory attributes as well as individual therapeutic approaches.
Appears in Collections:Artigos e Materiais de Revistas Científicas - HC/ICr
Artigos e Materiais de Revistas Científicas - LIM/36

Files in This Item:
File Description SizeFormat 
art_JHAMNANI_ClassSwitch_Recombination_CSRHyperIgM_HIGM_Syndromes_and_Phosphoinositide_3Kinase_2018.PDFpublishedVersion (English)880.34 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.